Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07510412 · ClinicalTrials.gov registry record · NA
Clinical Trial Evaluating NuShield® Plus Standard of Care (SOC) Versus Standard of Care (SOC) Alone in the Management of Non-Healing Venous Leg Ulcers (VLUs)
A NA study, sponsored by Organogenesis.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT07510412 is a NA study that is actively recruiting participants, run by Organogenesis. The registered enrollment target is 200 participants.
The verdict
NCT07510412, a NA study, is actively recruiting participants, sponsored by Organogenesis.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
A Prospective, Multi-Center, Randomized Controlled Clinical Trial Evaluating NuShield® plus Standard of Care (SOC) versus Standard of Care (SOC) alone in the Management of Non-Healing Venous Leg Ulcers (VLUs). The study is a prospective, multi-center, open label, RCT designed to collect subject outcome data on NuShield plus Standard of Care vs Standard of Care alone for the management of VLUs.
Interventions
- OTHER NuShield®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-03-18 |
| Est. Completion | 2029-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07510412
The ClinicalTrials.gov registry entry for NCT07510412 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Organogenesis, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NuShield® is the first listed.
NCT07510412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07510412 about?
NCT07510412 is a clinical study titled "Clinical Trial Evaluating NuShield® Plus Standard of Care (SOC) Versus Standard of Care (SOC) Alone in the Management of Non-Healing Venous Leg Ulcers (VLUs)". A Prospective, Multi-Center, Randomized Controlled Clinical Trial Evaluating NuShield® plus Standard of Care (SOC) versus Standard of Care (SOC) alone in the Management of Non-Healing Venous Leg Ulcers (VLUs). The study is a prospective, multi-center, open label, RCT designed to collect subject outc...
What is the current status of trial NCT07510412?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-03-18. Estimated completion is 2029-04.
What interventions are being tested in trial NCT07510412?
The interventions under investigation include: NuShield® (OTHER).
Who is sponsoring clinical trial NCT07510412?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.